文献速递腹部技术与安全心血管CT

光子计数CT腹部体成分参数预测代谢异常聚集模型

A Prediction Model for Metabolic Abnormality Clustering Based on Abdominal Body Composition Parameters From Photon-counting CT: Development and Internal Validation.
PubMed 文献 · Acad Radiol · 2026-09-30

回顾性纳入116例接受腹部光子计数CT(PCCT)患者,其中61例存在代谢异常聚集。多因素回归显示BMI与VAT/SAT比值为独立关联因素。临床、影像及联合模型AUC分别为0.812、0.754、0.841,联合模型较影像模型显著提升,但较临床模型无统计学差异。

要点

  • VAT/SAT比值是代谢异常聚集的独立影像学预测因素,可纳入报告。
  • 仅用年龄、性别、BMI的临床模型AUC已达0.812,影像增量有限。
  • 联合模型最佳阈值0.565时敏感度70.5%、特异度87.3%。

核心结论

  • PCCT来源的VAT/SAT比值与代谢异常聚集独立相关,联合年龄、性别、BMI的模型AUC达0.841。
  • 联合模型虽AUC最高,但区分度较单纯临床模型无统计学显著优势,尚需外部验证。

研究设计与样本

  • 回顾性单中心研究,入组116例接受腹部PCCT检查患者,其中代谢异常聚集组61例、非聚集组55例。
  • 代谢异常聚集定义为高血糖、高血压、高甘油三酯、低HDL-C四项中满足≥2项。
  • 影像参数包括内脏脂肪面积、VAT/SAT比值、骨骼肌指数、腰肌密度、肝脾比值。
  • 采用单因素及多因素logistic回归筛选独立关联因素,Bootstrap 1000次重抽样行内部验证。

关键影像表现/征象

  • PCCT可量化腹部体成分,其中VAT/SAT比值在代谢异常聚集组与非聚集组间存在差异。
  • VAT/SAT比值升高反映内脏脂肪相对皮下脂肪增多,是影像可测量的代谢风险征象。

诊断标准与关键数值

  • 代谢异常聚集标准:高血糖、高血压、高甘油三酯、低HDL-C四项中满足≥2项。
  • 联合模型多因素结果:BMI OR=1.476,95%CI 1.263-1.779,p<0.001;VAT/SAT比值 OR=4.093,95%CI 1.487-13.159,p=0.011。
  • 临床模型AUC=0.812;影像模型(VAT/SAT比值)AUC=0.754;联合模型AUC=0.841。
  • 联合模型与影像模型比较p=0.022;与临床模型比较p=0.143。
  • 联合模型最佳概率阈值0.565时,敏感度70.5%、特异度87.3%、阳性预测值86.0%、阴性预测值72.7%。

临床应用与阅片要点

  • 腹部PCCT报告中量化VAT/SAT比值可辅助识别代谢异常聚集风险,但单独影像学增量有限。
  • 日常评估代谢风险时年龄、性别、BMI应作为基础信息,影像体成分参数作为补充而非替代。
  • 联合模型可构建列线图计算代谢异常聚集概率,报告时可参考阈值0.565的决策点。

局限性

  • 单中心回顾性设计,样本量仅116例,结果需前瞻性多中心外部验证。
  • 联合模型区分度未显著优于单纯临床模型,影像参数的临床增量价值有限。
  • 代谢异常聚集采用研究自定义标准而非正式代谢综合征诊断标准,影响外推性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To investigate the association of photon-counting computed tomography (PCCT)-derived abdominal body composition parameters with metabolic abnormality clustering, and to develop and internally validate clinical, imaging, and combined models for risk assessment MATERIALS AND METHODS: We retrospectively enrolled 116 patients undergoing abdominal PCCT, including 61 with metabolic abnormality clustering and 55 without metabolic abnormality clustering. Metabolic abnormality clustering was defined using a study-specific criterion as the presence of ≥2 of the following: hyperglycemia, hypertension, hypertriglyceridemia, and low high-density lipoprotein cholesterol, for risk-oriented identification of concurrent metabolic abnormalities rather than diagnosis of metabolic syndrome. Clinical (age, sex, body mass index [BMI]) and imaging parameters (visceral fat area, visceral adipose tissue [VAT]/subcutaneous adipose tissue [SAT] ratio, skeletal muscle index, lumbar muscle density, and liver-to-spleen ratio) were collected. Univariable and multivariable logistic regression analyses were performed to identify factors independently associated with metabolic abnormality clustering. Three models were developed: a clinical model (age, sex, and BMI), an imaging model (VAT/SAT ratio), and a combined model incorporating the clinical variables and VAT/SAT ratio. Discrimination was assessed using the area under the receiver operating characteristic curve (AUC), with pairwise comparisons by the DeLong test. Clinical utility was explored using decision curve analysis (DCA). Internal validation was performed using 1000 bootstrap resamples. Calibration was assessed using calibration curves, and a nomogram was constructed based on the combined model.

RESULTS: BMI (odds ratio [OR] = 1.476, 95% confidence interval [CI]: 1.263-1.779, p < 0.001) and VAT/SAT ratio (OR = 4.093, 95% CI: 1.487-13.159, p = 0.011) were independently associated with metabolic abnormality clustering in the combined model. AUCs were 0.812 for the clinical model, 0.754 for the imaging model, and 0.841 for the combined model. The combined model outperformed the imaging model (p = 0.022) but not the clinical model (p = 0.143). Although the combined model had the numerically highest AUC, its discrimination was not statistically superior to that of the clinical model. Exploratory DCA suggested numerically higher net benefit for the combined model within a limited range of threshold probabilities. At the optimal probability threshold of 0.565, sensitivity, specificity, positive predictive value, and negative predictive value were 70.5%, 87.3%, 86.0%, and 72.7%, respectively. Bootstrap internal validation yielded an optimism-corrected C-index of 0.81, a calibration slope close to 1, and a mean absolute error of 0.038. A nomogram based on age, sex, BMI, and VAT/SAT ratio was developed to estimate the probability of metabolic abnormality clustering.

CONCLUSION: The PCCT-derived VAT/SAT ratio was independently associated with metabolic abnormality clustering. A combined model incorporating age, sex, BMI, and VAT/SAT ratio achieved an AUC of 0.841, although its discrimination was not significantly better than that of the clinical model alone. Further multicenter studies with external validation are warranted before clinical application.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang, Weng, Liu, et al. A Prediction Model for Metabolic Abnormality Clustering Based on Abdominal Body Composition Parameters From Photon-counting CT: Development and Internal Validation. Acad Radiol. 2026. PMID: 42816297. doi:10.1016/j.acra.2026.09.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。